KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Veronika Ramovs und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Embryology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands. Hauptthemen laut MEDLINE: Heart Failure, Intermediate Filaments, Mitochondria, Heart, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: DEBRA Austria, Novo Nordisk Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
A striking aspect of epidermolysis bullosa patients with a mutation in KLHL24 (KLHL24mut) is their life-threatening deterioration of heart function. KLHL24 is a component of the ubiquitin-proteasome system and acts as a substrate-specific adaptor protein for E3 ubiquitin ligase. KLHL24mut is thought to represent a gain-of-function mutation, with associated cardiac and skin pathologies arising from the excessive degradation of its target proteins. Although reduced desmin levels in cardiomyocytes (CMs) have already been documented, the potential involvement of additional mechanisms in KLHL24mut -driven heart pathology remains unexplored. Methods and results We report on two patients with KLHL24mut who recently manifested heart failure. To gain insights into their physiopathology, we integrated clinical data with proteomic analyses of heart tissue as well as human induced pluripotent stem cell (hiPSC) models carrying KLHL24mut. Mass spectrometry analysis of CMs differentiated from patient-derived hiPSCs mirrored the proteomic profile of their corresponding left ventricle tissue samples. KLHL24mut resulted in a reduction of several intermediate filaments (IF), mitochondrial and muscle fibre proteins as well as the emergence of an early fibrotic signature. By utilising various hiPSC-derived cardiac models along with flow cytometry, immunofluorescence, and western blot analyses, we confirmed that the excessive proteasomal activity of endogenous KLHL24mut caused a decrease in levels of desmin, synemin and vimentin, IF proteins of CMs and cardiac fibroblasts. Moreover, KLHL24mut led to mitochondrial mislocalization and increased mitophagy, reduced PKA activity, and sarcomere shortening in CMs.
Conclusion
The deterioration of heart function in patients with KLHL24mut is driven by excessive proteasome-dependent degradation of multiple IF proteins across various cardiac cell types. Monotypic hiPSC-derived CMs and end-stage patient-derived cardiac explants from patients exhibit similar features, uncovering early pathological mechanisms and identifying a list of potential novel KLHL24mut target proteins. Finally, our findings validate that hiPSC-derived CMs represent a relevant model for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy and Embryology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.
- The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.
- Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.
- Electron Microscopy Facility, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.
- Department of Radiology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, Netherlands.
ORCID-Profile: Cristina Has, Monique Jongbloed, Karine Raymond
Förderung
- DEBRA Austria
- Novo Nordisk Foundation
Zitieren
APA
Ramovs, V., Chen, H. S., Patra, A., Tjokrodirijo, R., van Veelen, P., Mulder, A. A., Koning, R. I., Stöger, L., Hubner, C., Ibañez-Arenas, R., Morales Catalan, B., Morandé, P., dell'Oro, R., Poblete, C., Schuster, A., Yubero, M. J., Palisson, F., Has, C., Jongbloed, M., …, & Raymond, K. (2025). KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf231
Vancouver
Ramovs V, Chen HS, Patra A, Tjokrodirijo R, van Veelen P, Mulder AA, et al. KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf231
BibTeX
@article{Ramovs2025,
author = {Ramovs, Veronika and Chen, H Sophia and Patra, Athina and Tjokrodirijo, Rayman and van Veelen, Peter and Mulder, Aat A and Koning, Roman I and Stöger, Lauran and Hubner, Catalina and Ibañez-Arenas, Rodrigo and Morales Catalan, Bernardo and Morandé, Pilar and dell'Oro, Rosario and Poblete, Cristian and Schuster, Andrés and Yubero, María Joao and Palisson, Francis and Has, Cristina and Jongbloed, Monique and Fuentes, Ignacia and Mummery, Christine L and Raymond, Karine},
title = {KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf231}
}
EUVIMED